China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong
· Delayed Price · Currency is HKD 4.910
-0.010 (-0.20%)
Apr 29, 2025, 2:45 PM HKT
HKG:3320 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 257,673 | 244,704 | 218,183 | 192,920 | 168,764 | Upgrade
|
| Revenue Growth (YoY) | 5.30% | 12.16% | 13.10% | 14.31% | -7.66% | Upgrade
|
| Cost of Revenue | 216,984 | 206,366 | 184,564 | 164,096 | 141,571 | Upgrade
|
| Gross Profit | 40,689 | 38,337 | 33,619 | 28,823 | 27,193 | Upgrade
|
| Selling, General & Admin | 26,557 | 25,252 | 21,999 | 19,383 | 18,198 | Upgrade
|
| Other Operating Expenses | 2,148 | 2,044 | 1,878 | 1,422 | 1,134 | Upgrade
|
| Operating Expenses | 28,705 | 27,296 | 23,878 | 20,805 | 19,332 | Upgrade
|
| Operating Income | 11,984 | 11,041 | 9,741 | 8,019 | 7,861 | Upgrade
|
| Interest Expense | -2,262 | -2,363 | -2,428 | -2,209 | -2,639 | Upgrade
|
| Interest & Investment Income | 681.1 | 587.69 | 721.18 | 595.97 | 572.74 | Upgrade
|
| Earnings From Equity Investments | 368.01 | 417.11 | 332.34 | 255.48 | 174.18 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,007 | 1,057 | 181.76 | 287.98 | 470.95 | Upgrade
|
| EBT Excluding Unusual Items | 11,778 | 10,741 | 8,549 | 6,950 | 6,439 | Upgrade
|
| Merger & Restructuring Charges | - | -9.98 | - | -7.02 | -1.13 | Upgrade
|
| Impairment of Goodwill | -92.23 | -82.81 | -85.14 | -100.82 | -495.24 | Upgrade
|
| Gain (Loss) on Sale of Investments | -720.41 | -220.69 | -166.16 | 101.66 | 90.83 | Upgrade
|
| Gain (Loss) on Sale of Assets | 70.12 | 63.85 | 334.84 | 7.83 | -15.03 | Upgrade
|
| Asset Writedown | -178.87 | -611.12 | -271.11 | -115.43 | -76.02 | Upgrade
|
| Other Unusual Items | 73.27 | - | - | 14.22 | 15.23 | Upgrade
|
| Pretax Income | 10,930 | 9,880 | 8,361 | 6,850 | 5,958 | Upgrade
|
| Income Tax Expense | 2,527 | 2,105 | 1,703 | 1,435 | 1,475 | Upgrade
|
| Earnings From Continuing Operations | 8,403 | 7,775 | 6,658 | 5,415 | 4,483 | Upgrade
|
| Minority Interest in Earnings | -5,052 | -3,921 | -3,158 | -2,345 | -1,706 | Upgrade
|
| Net Income | 3,351 | 3,854 | 3,500 | 3,070 | 2,776 | Upgrade
|
| Preferred Dividends & Other Adjustments | 19.59 | - | - | - | - | Upgrade
|
| Net Income to Common | 3,331 | 3,854 | 3,500 | 3,070 | 2,776 | Upgrade
|
| Net Income Growth | -13.06% | 10.11% | 14.00% | 10.59% | -5.50% | Upgrade
|
| Shares Outstanding (Basic) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | Upgrade
|
| Shares Outstanding (Diluted) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | Upgrade
|
| Shares Change (YoY) | - | - | - | -0.01% | -0.02% | Upgrade
|
| EPS (Basic) | 0.53 | 0.61 | 0.56 | 0.49 | 0.44 | Upgrade
|
| EPS (Diluted) | 0.53 | 0.61 | 0.56 | 0.49 | 0.44 | Upgrade
|
| EPS Growth | -13.57% | 10.11% | 14.00% | 10.60% | -5.48% | Upgrade
|
| Free Cash Flow | - | 13,027 | 8,542 | 8,495 | 5,504 | Upgrade
|
| Free Cash Flow Per Share | - | 2.07 | 1.36 | 1.35 | 0.88 | Upgrade
|
| Dividend Per Share | 0.135 | 0.154 | 0.142 | 0.122 | 0.101 | Upgrade
|
| Dividend Growth | -12.34% | 8.81% | 15.82% | 20.94% | 2.76% | Upgrade
|
| Gross Margin | 15.79% | 15.67% | 15.41% | 14.94% | 16.11% | Upgrade
|
| Operating Margin | 4.65% | 4.51% | 4.46% | 4.16% | 4.66% | Upgrade
|
| Profit Margin | 1.29% | 1.57% | 1.60% | 1.59% | 1.65% | Upgrade
|
| Free Cash Flow Margin | - | 5.32% | 3.91% | 4.40% | 3.26% | Upgrade
|
| EBITDA | 14,522 | 13,580 | 11,688 | 9,732 | 9,329 | Upgrade
|
| EBITDA Margin | 5.64% | 5.55% | 5.36% | 5.04% | 5.53% | Upgrade
|
| D&A For EBITDA | 2,539 | 2,539 | 1,947 | 1,713 | 1,468 | Upgrade
|
| EBIT | 11,984 | 11,041 | 9,741 | 8,019 | 7,861 | Upgrade
|
| EBIT Margin | 4.65% | 4.51% | 4.46% | 4.16% | 4.66% | Upgrade
|
| Effective Tax Rate | 23.12% | 21.31% | 20.37% | 20.94% | 24.76% | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.